CCMI
UTHR icon

Creative Capital Management Investments’s United Therapeutics UTHR Stock Holding History

Creative Capital Management Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42K Buy
+10
New +$5.63K ﹤0.01% 389
2026
Q1 		– Sell
-31
Closed -$15.1K – 343
2025
Q4 		$15.1K Buy
+31
New +$14.4K ﹤0.01% 187

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Creative Capital Management Investments's UTHR Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in United Therapeutics (UTHR) in Q2 2026: 10 shares worth $5.42K. The stake represents ﹤0.01% of the portfolio and ranks #389 among its holdings. This is a return to the name: Creative Capital Management Investments previously reported a position in UTHR as recently as Q4 2025.

Creative Capital Management Investments first reported a position in UTHR in Q4 2025 and has held it in 2 quarters since. The position peaked at $15.1K in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Creative Capital Management Investments held 10 shares of United Therapeutics worth $5.42K as of Q2 2026.
  • United Therapeutics was a new Creative Capital Management Investments position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #389 holding.
  • Creative Capital Management Investments first reported a position in United Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • Creative Capital Management Investments's United Therapeutics position peaked at $15.1K in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.